Stay updated with breaking news from Newly Diagnosed Multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3 Sarclisa, in combination
Experts discuss treatment in newly diagnosed multiple myeloma and the role of CAR T-cell therapies and bispecifics in relapsed/refractory disease.
A panel of experts discuss the evolving landscape of newly diagnosed multiple myeloma.
Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer
Expert panelists reflect on the continuing role of stem cell transplant in patients with newly diagnosed multiple myeloma.